Volker Lennerz

Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

Jennifer Landsberg, Judith Kohlmeyer, Marcel Renn et al. · Nature · 2012 · 641 citations

Medicine, Immunology, Oncology +14

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

Volker Lennerz, Martina Fatho, Chiara Gentilini et al. · Proceedings of the National Academy of Sciences · 2005 · 451 citations · Full text

Life Sciences, Immunology, Oncology +17

Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression

Antje Sucker, Fang Zhao, Birgit Real et al. · Clinical Cancer Research · 2014 · 167 citations · Full text

Life Sciences, Immunology, Oncology +17

Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors

Volker Lennerz, Elisa Gallerani, Cristiana Sessa et al. · Cancer Immunology Immunotherapy · 2014 · 126 citations · Full text

Medicine, Immunology, Oncology +16

Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53

Steffen C. Naumann, Wynand P. Roos, Eva Jöst et al. · British Journal of Cancer · 2009 · 101 citations · Full text

Medicine, Oncology, Pharmacology +17